| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health. Presently, the company markets Mytesi, an approved medication providing symptomatic relief for noninfectious diarrhea experienced by adults with HIV/AIDS undergoing antiretroviral therapy. Beyond its commercial product, Jaguar …
Over the last 12 months, insiders at Jaguar Health, Inc. have bought $0 and sold $0 worth of Jaguar Health, Inc. stock.
On average, over the past 5 years, insiders at Jaguar Health, Inc. have bought $10 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 317 shares for transaction amount of $10 was made by Wolin Jonathan S. (Chief of Staff, CCO & GC) on 2022‑12‑31.
| 2022-12-31 | Wolin Jonathan S. | Chief of Staff, CCO & GC | 317 <0.0001% | $0.03 | $10 | -91.64% | ||
| 2021-09-13 | CONTE LISA A | CEO and President | 7,968 0.163% | $2.51 | $20,000 | -83.43% | ||
| 2021-09-13 | Lizak Carol R. | Chief Financial Officer | 7,968 0.163% | $2.51 | $20,000 | -83.43% | ||
| 2021-06-04 | Sale | BOCHNOWSKI JAMES J | director | 152 0.0022% | $1.74 | $264 | -89.73% | |
| 2021-06-03 | Sale | BOCHNOWSKI JAMES J | director | 292 0.0042% | $1.75 | $511 | -89.90% | |
| 2019-07-23 | BOCHNOWSKI JAMES J | director | 180,582 2.9434% | $2.00 | $361,164 | -72.08% | ||
| 2019-07-23 | Siegel Jonathan B. | director | 12,705 0.2071% | $2.00 | $25,410 | -72.08% | ||
| 2018-10-04 | Siegel Jonathan B. | director | 25,000 0.1222% | $0.60 | $15,000 | |||
| 2018-09-25 | Sale | Nantucket Investments Ltd | 10 percent owner | 595,885 4.8563% | $1.00 | $595,875 | ||
| 2018-07-18 | Siegel Jonathan B. | director | 5,000 0.0446% | $1.10 | $5,476 | |||
| 2018-07-18 | CONTE LISA A | CEO and President | 1,500 0.0136% | $1.11 | $1,669 | |||
| 2018-07-17 | Siegel Jonathan B. | director | 268 0.0026% | $1.19 | $319 | |||
| 2018-07-16 | Siegel Jonathan B. | director | 7,500 0.083% | $1.36 | $10,190 | |||
| 2017-06-28 | BOCHNOWSKI JAMES J | director | 100,000 0.4075% | $0.50 | $50,000 | |||
| 2016-02-08 | BOCHNOWSKI JAMES J | director | 160,000 3.2599% | $2.50 | $400,000 |
| Increased Positions | 6 | +75% | 43,182 | +45.22% |
| Decreased Positions | 2 | -25% | 73,155 | -76.61% |
| New Positions | 3 | New | 36,544 | New |
| Sold Out Positions | <1 | Sold Out | 10 | Sold Out |
| Total Postitions | 12 | +50% | 65,515 | -31.39% |
| Drw Securities, Llc | $91.00 | 2.27% | 90,968 | +90,968 | New | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.09% | 3,381 | +1,790 | +112.51% | 2025-09-30 |
| Royal Bank Of Canada | $1.00 | 0.02% | 702 | 0 | 0% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $0 | 0.01% | 220 | +20 | +10% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | 0% | 14 | +10 | +250% | 2025-09-30 |
| Morgan Stanley | $0 | 0% | 10 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $0 | 0% | 4 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $0 | 0% | 1 | -11,172 | -99.99% | 2025-09-30 |